Latest Argus II Stories
FORT LAUDERDALE, Fla., May 3, 2011 /PRNewswire/ -- Exciting results from the Argus(TM) II Retinal Prosthesis System ('Argus II') clinical trial were presented today at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2011 Annual Meeting.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.